The Research Support Core is requested for a centralized collection and processing of blood for RT-PCR and for serum and lymphocytes, and tumor tissues for different projected under the overall program. This will be done to promote uniformity in handing and record keeping of the samples that will be received from various centers participating in the trial and from JWCI. Centralized collection and processing of the samples will allow efficient use of materials, reduce the frequency of venipuncture, and allow maintenance of the process uniformly. Procedures will include the following: 1. Serum received from outside centers will be inspected for their physical appearance and tallied with the packing list. After quality control inspection and appropriate logging and record keeping, the samples will be immediately forwarded to the appropriate laboratory in a coded manner. Blood samples received from JWCI will be processed to collect serum which will be inventoried and recorded in the database, and will be distributed to appropriate laboratories. 2. Blood for RT-PCR will be forwarded immediately after receipt to the appropriate laboratory. Appropriate records will be logged in the database. 3. Bloods collected for lymphocytes at JWCI or received from outside patients will be processed centrally in a uniform manner, cyropreserved and archived. 4. Tumor tissues received from JWCI will be processed for cryopreservation. The specimens upon receipt will be checked for accuracy of the information and appropriateness of the forms. To maintain confidentiality, the specimens will be coded and appropriate records maintained at a central location.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA029605-17
Application #
6269125
Study Section
Project Start
1998-09-10
Project End
1998-11-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
17
Fiscal Year
1998
Total Cost
Indirect Cost
Name
John Wayne Cancer Institute
Department
Type
DUNS #
556074458
City
Santa Monica
State
CA
Country
United States
Zip Code
90404
Jones, Maris S; Lee, Jihey; Stern, Stacey L et al. (2017) Is Pregnancy-Associated Melanoma Associated with Adverse Outcomes? J Am Coll Surg 225:149-158
Faries, Mark B; Thompson, John F; Cochran, Alistair J et al. (2017) Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med 376:2211-2222
Ozao-Choy, Junko; Nelson, Daniel W; Hiles, Jason et al. (2017) The prognostic importance of scalp location in primary head and neck melanoma. J Surg Oncol 116:337-343
Karakousis, Giorgos; Gimotty, Phyllis A; Bartlett, Edmund K et al. (2017) Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis. Ann Surg Oncol 24:952-959
Jones, Maris S; Torisu-Itakura, Hitoe; Flaherty, Devin C et al. (2016) Second Primary Melanoma: Risk Factors, Histopathologic Features, Survival, and Implications for Follow-Up. Am Surg 82:1009-1013
Faries, Mark B (2016) Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology. Crit Rev Oncog 21:65-73
Faries, M B; Cochran, A J; Elashoff, R M et al. (2015) Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: response to 'No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of t Br J Dermatol 172:571-3
Lessard, Laurent; Liu, Michelle; Marzese, Diego M et al. (2015) The CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype Switching. J Invest Dermatol 135:2464-2474
Deutsch, Gary B; Kirchoff, Daniel D; Faries, Mark B (2015) Metastasectomy for stage IV melanoma. Surg Oncol Clin N Am 24:279-98
Marzese, Diego M; Hoon, Dave Sb (2015) Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer. Expert Rev Mol Diagn 15:647-64

Showing the most recent 10 out of 256 publications